These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24283997)

  • 1. Diabetes mellitus and non-muscle-invasive bladder cancer: not just a coincidence?
    Cresswell J
    BJU Int; 2013 Dec; 112(8):1055-6. PubMed ID: 24283997
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
    BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
    Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
    Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
    Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL
    Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Weckermann D
    Eur Urol; 2014 Jul; 66(1):174-5. PubMed ID: 24929079
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Taneja SS
    J Urol; 2014 Jun; 191(6):1783. PubMed ID: 25280280
    [No Abstract]   [Full Text] [Related]  

  • 8. Metformin use improves the survival of diabetic combined small-cell lung cancer patients.
    Kong F; Gao F; Liu H; Chen L; Zheng R; Yu J; Li X; Liu G; Jia Y
    Tumour Biol; 2015 Sep; 36(10):8101-6. PubMed ID: 25983003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What Is the effect of metformin combined to chemotherapy in stage IV colorectal cancer with diabetes?].
    Jung JT
    Korean J Gastroenterol; 2012 Dec; 60(6):343-4. PubMed ID: 23367542
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of treatment of adult diabetes mellitus with Metformin-sulfonamide combination (apropos of 197 cases)].
    Debry G; Laurent J
    J Med Lyon; 1966 Mar; 47(94):407-13. PubMed ID: 5909923
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between metformin use and mortality in patients with prostate cancer: explained by confounding by indication?
    Zanders MM; Vissers PA; van de Poll-Franse LV
    J Clin Oncol; 2014 Mar; 32(7):701. PubMed ID: 24395861
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major.
    Dhouib N; Turki Z; Mellouli F; Ouederni M; Yahiaoui S; Nagi S; Ben Slama C; Bejaoui M
    Tunis Med; 2010 Feb; 88(2):136. PubMed ID: 20415181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-oncogenic effect of metformin].
    Noto H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():693-6. PubMed ID: 27266176
    [No Abstract]   [Full Text] [Related]  

  • 14. Metformin as Initial Oral Therapy in Type 2 Diabetes.
    Stern RJ; Murphy EJ
    JAMA; 2015 Jun 23-30; 313(24):2484-5. PubMed ID: 26103032
    [No Abstract]   [Full Text] [Related]  

  • 15. A pharmacist's perspective on metformin use and cancer outcomes.
    Ceacareanu AC
    J Pharm Pract; 2015 Feb; 28(1):44-5. PubMed ID: 25715081
    [No Abstract]   [Full Text] [Related]  

  • 16. [Type 2 diabetes: Metformin: first choice at the start of therapy].
    Gallwitz B
    Dtsch Med Wochenschr; 2015 Feb; 140(4):236. PubMed ID: 25704514
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial therapy for diabetes mellitus.
    Segal JB; Maruthur NM
    JAMA Intern Med; 2014 Dec; 174(12):1962-3. PubMed ID: 25347083
    [No Abstract]   [Full Text] [Related]  

  • 18. Metformin as an addition to conventional chemotherapy in breast cancer.
    Grenader T; Goldberg A; Shavit L
    J Clin Oncol; 2009 Dec; 27(35):e259; author reply e260. PubMed ID: 19884518
    [No Abstract]   [Full Text] [Related]  

  • 19. Metformin and mortality.
    Lund SS
    Diabetologia; 2013 Apr; 56(4):937-8. PubMed ID: 23377620
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin does not improve survival of cholangiocarcinoma patients with diabetes.
    Yang Z; Zhang X; Roberts RO; Roberts LR; Chaiteerakij R
    Hepatology; 2016 Feb; 63(2):667-8. PubMed ID: 25833233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.